What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature by David Goldstein, Richard Hubner, Angela Lamarca, Lipika Goyal, Junji Furuse, Tanios Bekaii-Saab, Jennifer Knox, Mairéad G McNamara, Juan Valle, Rachna Shroff, Chigusa Morizane, Lorenza Rimassa, John Bridgewater, Timothy Jacobs, Anna D Wagner, Markus Moehler, Maeve Lowery, Robin K Kelley

Get full text

Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer by Suhasini Joshi, Erica DaGama Gomes, Tai Wang, Adriana Corben, Tony Taldone, Srinivasa Gandu, Chao Xu, Sahil Sharma, Salma Buddaseth, Pengrong Yan, Lon Yin L. Chan, Askan Gokce, Vinagolu K. Rajasekhar, Lisa Shrestha, Palak Panchal, Justina Almodovar, Chander S. Digwal, Anna Rodina, Swathi Merugu, NagaVaraKishore Pillarsetty, Vlad Miclea, Radu I. Peter, Wanyan Wang, Stephen D. Ginsberg, Laura Tang, Marissa Mattar, Elisa de Stanchina, Kenneth H. Yu, Maeve Lowery, Olivera Grbovic-Huezo, Eileen M. O’Reilly, Yelena Janjigian, John H. Healey, William R. Jarnagin, Peter J. Allen, Chris Sander, Hediye Erdjument-Bromage, Thomas A. Neubert, Steven D. Leach, Gabriela Chiosis

Get full text